Moderna (MRNA) PT Lowered to $40 at Barclays
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $145.13 +8.86%
Rating Summary:
6 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on Moderna (NASDAQ: MRNA) to $40.00 (from $45.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $77 at JPMorgan
- Morgan Stanley Upgrades Merck (MRK) to Overweight
- Moderna (MRNA) call put ratio 1 calls to 2.1 puts amid wide price movement
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
